Minerva Neurosciences, Inc.NERVNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
-51.60%
↓ 25918% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-0.20%
Historical baseline
PeriodValue
2025-51.60%
2024-6.35%
2023-13.27%
2022-54.28%
202145.37%
2020-62.08%
201966.59%
201815.31%
201748.02%
201610.29%